Roundtable Discussion: Navigating Regulatory Expectations for Next-Generation Cell Therapies to Accelerate Translation to the Clinic
- Discussing evolving regulatory requirements for CAR-T, TCR, cell therapies to align with compliance standards
- Exploring how regulators are adapting to next-generation modalities, including in vivo delivery and manufacturing innovations
- Identifying strategies to design development programs that meet regulatory expectations while accelerating clinical translation